BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6883934)

  • 1. Estrogen-induced pancreatitis.
    Parker WA
    Clin Pharm; 1983; 2(1):75-9. PubMed ID: 6883934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperlipidaemia and pancreatitis associated with oral contraceptive therapy.
    Mehrotra TN; Dwivedi KK; Singh MM; Mittal HS; Singh VS
    J Assoc Physicians India; 1975 Feb; 23(2):161-4. PubMed ID: 1184540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Letter: Acute pancreatitis and hyperlipemia under oral contraceptives].
    Jubelin J; Vague J
    Nouv Presse Med; 1974 Jul; 3(27):1725. PubMed ID: 4845428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birth control pills and pancreatitis.
    Liu JW
    Md State Med J; 1982 Feb; 31(2):66-7. PubMed ID: 7070128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of pregnancy and two different contraceptive pills on serum lipids and lipoproteins in a woman with a type III hyperlipoproteinaemia pattern.
    Muller DP; Pavlou C; Whitelaw AG; McLintock D
    Br J Obstet Gynaecol; 1978 Feb; 85(2):127-33. PubMed ID: 626721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral contraceptive-induced pancreatitis in the hyperchylomicronemia syndrome].
    Schaefer JR; Steinmetz A; Dugi K; Ehlenz K; von Wichert P; Kaffarnik H
    Dtsch Med Wochenschr; 1995 Mar; 120(10):325-8. PubMed ID: 7875068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy.
    Davidoff F; Tishler S; Rosoff C
    N Engl J Med; 1973 Sep; 289(11):552-5. PubMed ID: 4723103
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral contraceptive-induced ischemic bowel disease.
    Parker WA; Morris ME; Shearer CA
    Am J Hosp Pharm; 1979 Aug; 36(8):1103-7. PubMed ID: 484572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Do's and don'ts for a woman who has an abnormal lipid pattern and is taking oral contraceptives].
    Boyet F
    Contracept Fertil Sex (Paris); 1984 Sep; 12(9):1076-7. PubMed ID: 12266510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined-type oral contraceptives and plasma triglyceride and cholesterol levels of young women.
    Tangney CC; Driskell JA
    Nutr Rep Int; 1977 Jul; 16(1):139-46. PubMed ID: 12335121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of acute pancreatitis with hyperlipemia and hyperglycemia induced by alcohol abuse.
    Kawanishi M; Okamoto S; Nishimura Y; Yoshikawa M; Kajiyama G
    Hiroshima J Med Sci; 1994 Mar; 43(1):31-6. PubMed ID: 8014072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.
    Whitcroft SI; Crook D; Marsh MS; Ellerington MC; Whitehead MI; Stevenson JC
    Obstet Gynecol; 1994 Aug; 84(2):222-6. PubMed ID: 8041534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cholestatic icterus due to oral contraceptives].
    Pestel M; Lambert C; Jeanmougin M
    Ann Med Interne (Paris); 1973 Mar; 124(3):207-9. PubMed ID: 4268576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolic risks of oral contraception].
    Monier L
    Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectivity and acceptability of oral contraceptives containing natural and artificial estrogens in combination with a gestagen. A controlled double-blind investigation.
    Serup J; Bostofte E; Larsen S; Westergaard J
    Acta Obstet Gynecol Scand; 1981; 60(2):203-6. PubMed ID: 7018165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Massive hyperlipemia during estrogen therapy.
    Molitch ME; Oill P; Odell WD
    JAMA; 1974 Feb; 227(5):522-5. PubMed ID: 4358883
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
    Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
    Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.